Verition Fund Management’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-281,196
Closed -$4.34M 3395
2025
Q4
$4.34M Buy
281,196
+112,653
+67% +$2.07M 0.02% 972
2025
Q3
$3.65M Sell
168,543
-88,914
-35% -$1.98M 0.02% 1470
2025
Q2
$5.72M Sell
257,457
-898,488
-78% -$20M 0.03% 974
2025
Q1
$27.5M Buy
+1,155,945
New +$27.4M 0.13% 137
2024
Q3
Sell
-42,866
Closed -$1.02M 3485
2024
Q2
$1.02M Buy
+42,866
New +$1.1M 0.01% 1659
2023
Q3
Sell
-4,962
Closed -$223K 2646
2023
Q2
$223K Buy
+4,962
New +$189K ﹤0.01% 1765

Other funds holding SGRY

Verition Fund Management's SGRY Position: Q1 2026 in Review

Verition Fund Management sold out of Surgery Partners (SGRY) in Q1 2026, closing a stake of 281,196 shares — an estimated $4.34M sold.

Verition Fund Management first reported a position in SGRY in Q2 2023 and held it in 6 quarters. The position peaked at $27.5M in Q1 2025. 182 funds tracked by Wall St. Rank hold SGRY as of Q1 2026.

  • Verition Fund Management reported no remaining Surgery Partners position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 281,196 Surgery Partners shares in Q1 2026, an estimated $4.34M.
  • Verition Fund Management first reported a position in Surgery Partners in Q2 2023 and held it in 6 quarters.
  • Verition Fund Management's Surgery Partners position peaked at $27.5M in Q1 2025.
  • 182 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.